• \citet{Mills_2017} describe a 22-year-old man with schizophrenia who developed tics on olanzapine after tapering risperidone. The authors are appropriately cautious in presenting this as a possible case of secondary tics, but given that many people with tics are unaware of the diagnosis, and the fact that olanzapine on average effectively treats tics, this case is much more likely to represent a previously undiagnosed primary tic disorder than a side effect of olanzapine.
  • The future of RDoC as discussed by the new director of NIMH (http://www.webcitation.org/6sccx8sIA).